Last reviewed · How we verify

NCT05261529: EFINUTRILES

Effects of an Intervention With EVOO and Physical Activity in Patients With Systemic Lupus Erythematosus

Status unknown NA Last updated 20 December 2022
What this trial tests

NA trial testing Extra Virgin Olive Oil (EVOO) in Lupus Erythematosus, Systemic in 90 participants. Status unknown.

Timeline
3 November 2021
Primary endpoint
30 December 2022
30 June 2023

Quick facts

Lead sponsorUniversidad de Granada
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment90
Start date3 November 2021
Primary completion30 December 2022
Estimated completion30 June 2023
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad de Granada — full company profile →

Who can join

Adults 18 to 70, female only, with Lupus Erythematosus, Systemic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In addition to the different pharmacological therapies available for the treatment of Systemic Lupus Erythematosus (SLE) as well as for its numerous associated complications (cutaneous, articular, hematological, neuropsychiatric, renal...), it has recently been proposed that 'health-related lifestyles' could have a determining role in balancing numerous organic processes at all levels. In line with this, the benefits of following a healthy dietary pattern such as the Mediterranean Diet and, specifically, the intake of Extra Virgin Olive Oil (EVOO) as well as the realization of regular physical exercise (PE) have been examined in numerous chronic non-communicable diseases such as obesity or cancer. However, in patients with autoimmune diseases, such as SLE, the possible effects of this synergy has not been investigated to date. Having demonstrated both the protective effect of a healthy dietary pattern and that of regular PE on the progression and risks associated with SLE in cross-sectional studies, non-intervention research has been developed that combines both strategies simultaneously, with nutritional supplementation or PE occurring independently. It is hypothesized that supplementation with EVOO in these patients together with PE will produce superior benefits compared to EVOO supplementation alone, showing changes in the phenotype of SLE and other parameters such as levels of chronicity/gravity, biomarkers (oxidative stress, immunological, inflammation), cardiovascular status and body composition.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. EFINUTRILES Study: Integrative Extra Virgin Olive Oil and Multimodal Lifestyle Interventions for Cardiovascular Health and SLE Management.
    Gil-Gutiérrez R, Medina-Martínez I, Quesada-Caballero M, de la Hera-Fernández FJ, et al · · 2025 · cited 1× · PMID 40292522 · DOI 10.3390/nu17061076
  2. Profiling miRNA in Systemic Lupus Erythematosus Patients Adhering to a Mediterranean Diet: An Interventional Pilot Study
    Gil-Gutiérrez R, Medina-Martínez I, Membrive-Jiménez M, Caballero-Mateos A, et al · · 2026

Verify or expand the search:

Other trials of Extra Virgin Olive Oil (EVOO)

Trials testing the same drug.

Other recruiting trials for Lupus Erythematosus, Systemic

Currently open trials in the same condition.

Other Universidad de Granada trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05261529.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing